| Product Code: ETC9978757 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Valganciclovir Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Valganciclovir Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Valganciclovir Market - Industry Life Cycle |
3.4 United States (US) Valganciclovir Market - Porter's Five Forces |
3.5 United States (US) Valganciclovir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Valganciclovir Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Valganciclovir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cytomegalovirus (CMV) infections in the US |
4.2.2 Growing awareness about the effectiveness of valganciclovir in treating CMV infections |
4.2.3 Rising demand for antiviral medications in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and marketing of valganciclovir |
4.3.2 High cost associated with valganciclovir treatment |
4.3.3 Potential side effects and adverse reactions of valganciclovir |
5 United States (US) Valganciclovir Market Trends |
6 United States (US) Valganciclovir Market, By Types |
6.1 United States (US) Valganciclovir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Valganciclovir Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Valganciclovir Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.4 United States (US) Valganciclovir Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2 United States (US) Valganciclovir Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Valganciclovir Market Revenues & Volume, By Adults, 2021- 2031F |
6.2.3 United States (US) Valganciclovir Market Revenues & Volume, By Children, 2021- 2031F |
7 United States (US) Valganciclovir Market Import-Export Trade Statistics |
7.1 United States (US) Valganciclovir Market Export to Major Countries |
7.2 United States (US) Valganciclovir Market Imports from Major Countries |
8 United States (US) Valganciclovir Market Key Performance Indicators |
8.1 Number of prescriptions for valganciclovir in the US |
8.2 Patient adherence rate to valganciclovir treatment |
8.3 Rate of CMV infections diagnosed and treated with valganciclovir in the US |
9 United States (US) Valganciclovir Market - Opportunity Assessment |
9.1 United States (US) Valganciclovir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Valganciclovir Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Valganciclovir Market - Competitive Landscape |
10.1 United States (US) Valganciclovir Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Valganciclovir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here